Total Holdings
52
Portfolio diversification across 52 positions
FTXH
(NASDAQ)First Trust Nasdaq Pharmaceuticals ETF
$34.20-- (--)
Loading... - Market loading
FTXH ETF Holdings: First Trust Nasdaq Pharmaceuticals ETF
Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Assets Under Management
$29.30M
Total fund assets
Expense Ratio
0.60%
Annual management fee
Fund Issuer
First Trust
NASDAQ
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 49 Holdings by Portfolio Weight
View ticker symbols, company names, asset types, and allocation percentages for each position
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | Merck & Co., Inc | Stock | 7.98% |
| 2 | B BMY | Bristol-Myers Squibb Company | Stock | 7.45% |
| 3 |  | Johnson & Johnson | Stock | 7.40% |
| 4 |  | AbbVie Inc. | Stock | 6.98% |
| 5 |  | Eli Lilly and Company | Stock | 6.83% |
| 6 |  | Pfizer Inc | Stock | 6.18% |
| 7 |  | Biogen Inc | Stock | 4.18% |
| 8 |  | Regeneron Pharmaceuticals, Inc | Stock | 4.17% |
| 9 |  | Cardinal Health, Inc | Stock | 4.12% |
| 10 |  | Vertex Pharmaceuticals Incorporated | Stock | 3.63% |
| 11 |  | Viatris Inc | Stock | 3.61% |
| 12 |  | Gilead Sciences, Inc. | Stock | 3.55% |
| 13 |  | Amgen Inc | Stock | 3.47% |
| 14 |  | Zoetis Inc. | Stock | 3.37% |
| 15 |  | United Therapeutics Corporation | Stock | 3.32% |
| 16 |  | Jazz Pharmaceuticals plc | Stock | 2.28% |
| 17 |  | Incyte Corporation | Stock | 2.20% |
| 18 |  | Illumina, Inc | Stock | 2.20% |
| 19 |  | PTC Therapeutics, Inc | Stock | 1.66% |
| 20 |  | Charles River Laboratories International, Inc | Stock | 1.60% |
| 21 |  | Exelixis, Inc. | Stock | 1.54% |
| 22 |  | Medpace Holdings, Inc. | Stock | 1.44% |
| 23 |  | BioMarin Pharmaceutical Inc. | Stock | 1.23% |
| 24 |  | Arrowhead Pharmaceuticals, Inc | Stock | 1.21% |
| 25 |  | Neurocrine Biosciences, Inc. | Stock | 1.19% |
| 26 |  | Halozyme Therapeutics, Inc. | Stock | 1.12% |
| 27 |  | Elanco Animal Health Incorporated | Stock | 1.09% |
| 28 |  | Ionis Pharmaceuticals, Inc | Stock | 0.79% |
| 29 |  | Alkermes plc | Stock | 0.76% |
| 30 |  | Amneal Pharmaceuticals, Inc | Stock | 0.75% |
| 31 |  | Krystal Biotech, Inc | Stock | 0.69% |
| 32 |  | Guardant Health, Inc | Stock | 0.66% |
| 33 |  | BridgeBio Pharma, Inc | Stock | 0.59% |
| 34 |  | Protagonist Therapeutics Inc | Stock | 0.56% |
| 35 |  | Madrigal Pharmaceuticals, Inc | Stock | 0.52% |
| 36 |  | Insmed Incorporated | Stock | 0.52% |
| 37 |  | Ligand Pharmaceuticals Incorporated | Stock | 0.51% |
| 38 |  | Supernus Pharmaceuticals, Inc | Stock | 0.47% |
| 39 |  | Catalyst Pharmaceuticals Inc | Stock | 0.46% |
| 40 |  | Mirum Pharmaceuticals Inc | Stock | 0.45% |
| 41 |  | ADMA Biologics, Inc | Stock | 0.43% |
| 42 |  | TG Therapeutics, Inc | Stock | 0.43% |
| 43 |  | ACADIA Pharmaceuticals Inc | Stock | 0.43% |
| 44 |  | Prestige Consumer Healthcare Inc | Stock | 0.41% |
| 45 |  | Rhythm Pharmaceuticals, Inc | Stock | 0.39% |
| 46 |  | Tempus AI, Inc. Class A Common Stock | Stock | 0.37% |
| 47 |  | Alnylam Pharmaceuticals, Inc | Stock | 0.37% |
| 48 |  | Perrigo Company plc | Stock | 0.33% |
| 49 |  | Corcept Therapeutics Incorporated | Stock | 0.22% |
Frequently Asked Questions About First Trust Nasdaq Pharmaceuticals ETF Holdings
What are the top holdings in FTXH?
First Trust Nasdaq Pharmaceuticals ETF (FTXH) holds 52 securities. View the complete list of top holdings sorted by portfolio weight, showing each security's ticker symbol, company name, asset type, and allocation percentage.
How concentrated is FTXH's portfolio?
Portfolio concentration is measured by the weight of top holdings. A concentrated portfolio has fewer large positions with higher individual weights, while a diversified portfolio distributes holdings more evenly. Review FTXH's holdings table to analyze concentration risk.
What is FTXH's sector allocation?
The Sector Allocation chart shows how FTXH distributes investments across different industries like Technology, Healthcare, Financials, and more. This sector exposure helps understand the fund's industry diversification strategy.
What countries does FTXH invest in?
FTXH's geographic exposure is shown in the Countries tab under Portfolio Allocations. This reveals the fund's international diversification and exposure to different regions and global markets.
How diversified is FTXH ETF?
FTXH's diversification can be assessed by reviewing its 52 holdings, sector allocation, and geographic exposure. A well-diversified ETF spreads investments across multiple securities, sectors, and regions to reduce concentration risk.